Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Truncated somatostatin receptors as new players in somatostatin–cortistatin pathophysiology
José Córdoba‐Chacón, Manuel D. Gahete, Mario Durán‐Prado, et al.
Annals of the New York Academy of Sciences (2011) Vol. 1220, Iss. 1, pp. 6-15
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Albert Beckers, Lauri A. Aaltonen, Adrian Daly, et al.
Endocrine Reviews (2013) Vol. 34, Iss. 2, pp. 239-277
Open Access | Times Cited: 326
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
Thomas Günther, Giovanni Tulipano, Pascal Dournaud, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 4, pp. 763-835
Open Access | Times Cited: 208
Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases
Lila Carniglia, Delia Ramírez, Daniela Durand, et al.
Mediators of Inflammation (2017) Vol. 2017, pp. 1-23
Open Access | Times Cited: 203
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
Antonio C. Fuentes-Fayos, Mari C. Vázquez‐Borrego, Juan M. Jiménez‐Vacas, et al.
Brain (2020) Vol. 143, Iss. 11, pp. 3273-3293
Open Access | Times Cited: 78
Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches
Kjell Öberg, Oriol Casanovas, Justo P. Castaño, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 11, pp. 2842-2849
Closed Access | Times Cited: 86
Illuminating somatostatin analog action at neuroendocrine tumor receptors
Jean Claude Reubi, Agnes Schönbrunn
Trends in Pharmacological Sciences (2013) Vol. 34, Iss. 12, pp. 676-688
Open Access | Times Cited: 85
Somatostatinergic systems: an update on brain functions in normal and pathological aging
Guillaume Martel, P. Dutar, Jacques Epelbaum, et al.
Frontiers in Endocrinology (2012) Vol. 3
Open Access | Times Cited: 84
Neuroendocrine regulation of somatic growth in fishes
Xiangyan Dai, Wei Zhang, Zijian Zhuo, et al.
Science China Life Sciences (2015) Vol. 58, Iss. 2, pp. 137-147
Open Access | Times Cited: 75
Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
B Mayr, Rolf Buslei, Marily Theodoropoulou, et al.
European Journal of Endocrinology (2013) Vol. 169, Iss. 4, pp. 391-400
Open Access | Times Cited: 70
Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation
Sophie Mary, Jean‐Alain Fehrentz, Marjorie Damian, et al.
Journal of Biological Chemistry (2013) Vol. 288, Iss. 34, pp. 24656-24665
Open Access | Times Cited: 54
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
Federico Gatto, Federica Barbieri, Marica Arvigo, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3940-3940
Open Access | Times Cited: 36
Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma
Miguel E. G-García, Ana S De la Rosa-Herencia, Álvaro Flores‐Martínez, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Activation of Brain Somatostatin Signaling Suppresses CRF Receptor-Mediated Stress Response
Andreas Stengel, Yvette Taché
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 34
Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons
Cara Ruble, Ryan M. Smith, John Calley, et al.
BMC Genomic Data (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Massimiliano Ruscica, Marica Arvigo, Liliana Steffani, et al.
Current Molecular Medicine (2013) Vol. 13, Iss. 4, pp. 555-571
Closed Access | Times Cited: 34
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer
Sergio Pedraza‐Arévalo, Daniel Hormaechea‐Agulla, Enrique Gómez‐Gómez, et al.
The Prostate (2017) Vol. 77, Iss. 15, pp. 1499-1511
Closed Access | Times Cited: 33
The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer
Manel Puig‐Domingo, Raúl M. Luque, Jordi L. Reverter, et al.
PLoS ONE (2014) Vol. 9, Iss. 1, pp. e85527-e85527
Open Access | Times Cited: 31
Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges
Justo P. Castaño, Anders Sundin, Helmut R. Maëcke, et al.
Cancer and Metastasis Reviews (2014) Vol. 33, Iss. 1, pp. 353-359
Closed Access | Times Cited: 31
Peptides derived from the extracellular domain of the somatostatin receptor splicing variant SST5TMD4 increase malignancy in multiple cancer cell types
Mercedes del Río-Moreno, Emilia Alors‐Pérez, Patricia Borges de Souza, et al.
Translational research (2019) Vol. 211, pp. 147-160
Open Access | Times Cited: 22
Intron retention of an adhesion GPCR generates 1TM isoforms required for 7TM-GPCR function
Anne Bormann, Marek B. Körner, Anne-Kristin Dahse, et al.
Cell Reports (2024) Vol. 44, Iss. 1, pp. 115078-115078
Closed Access | Times Cited: 2
Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes
Andreas Stengel, Jean Rivier, Yvette Taché
Peptides (2012) Vol. 42, pp. 70-77
Open Access | Times Cited: 23
Neuroendocrinology: a short historical review
Roger Guillemin
Annals of the New York Academy of Sciences (2011) Vol. 1220, Iss. 1, pp. 1-5
Closed Access | Times Cited: 22
Targeting the somatostatin receptor in pituitary and neuroendocrine tumors
Marije J Veenstra, Wouter W. de Herder, Richard A. Feelders, et al.
Expert Opinion on Therapeutic Targets (2013) Vol. 17, Iss. 11, pp. 1329-1343
Closed Access | Times Cited: 21
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells
Daniela Molè, Erica Gentilin, Alejandro Ibáñez‐Costa, et al.
Endocrine (2015) Vol. 50, Iss. 2, pp. 442-452
Closed Access | Times Cited: 19
The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
Manuel D. Gahete, David Rincon Fernandez Pacheco, Mario Durán‐Prado, et al.
Oncotarget (2016) Vol. 7, Iss. 37, pp. 60110-60122
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top